Nifedipine induces gingival overgrowth in rats through a reduction in collagen phagocytosis by gingival fibroblasts

Journal of Periodontology

Volumn 72, Issue 8, 2001, Pages 1078-1083

  Kataoka, Masatoshi ^a   Shimizu, Yasuki ^a   Kunikiyo, Kenji ^a   Asahara, Yoji ^a   Azuma, Hideki ^a   Sawa, Takamasa ^a   Kido, Jun Ichi ^a   Nagata, Toshihiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Animal studies; Collagen metabolism; Gingival hyperplasia etiology; Nifedipine adverse effects

Indexed keywords

NIFEDIPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLLAGEN DEGRADATION; DRUG EFFECT; FIBROBLAST; GINGIVA; GINGIVA HYPERPLASIA; MALE; NONHUMAN; PHAGOCYTOSIS; RAT;

ANIMALS; CELLS, CULTURED; COLLAGEN; FIBROBLASTS; FLOW CYTOMETRY; GINGIVA; GINGIVAL OVERGROWTH; IMMUNOHISTOCHEMISTRY; MALE; NIFEDIPINE; PHAGOCYTOSIS; RATS; RATS, INBRED F344; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; VASODILATOR AGENTS;

EID: 0034886610     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2001.72.8.1078     Document Type: Article

References (30)

1. Ferlinz J. Nifedipine in myocardial ischemia hypertension and other cardiovascular disorders. Ann Intern Med 1986;105:714-729.
2. Ramon Y, Behar S, Kistron Y, Engelberg IS. Gingival hyperplasia caused by nifedipine - a preliminary report. Int J Cardiol 1984;5:195-204.
3. Lucas RM, Howell LP, Wall BA. Nifedipine-induced gingival hyperplasia. J Periodontol 1985;56:211-215.
4. Barak S, Engelberg IS, Hiss J. Gingival hyperplasia caused by nifedipine. J Periodontol 1987;58:639-642.
5. Perez-Tamayo R. Pathology of collagen degradation. Am J Pathol 1978;92:509-566.
6. Goultschin J, Shoshan S. Inhibition of collagen break-down by diphenylhydantoin. Biochim Biophys Acta 1980; 631:188-191.
7. Murphy G, Reynolds JJ. Current views of collagen degradation: Progress towards understanding the resorption of connective tissues. Bioessays 1984;2:55-60.
8. Everts V, Beertsen W, Tigchelaar-Gutter W. The digestion of phagocytosed collagen is inhibited by the proteinase inhibitors leupeptin and E-64. Coll Relat Res 1985;5:315-336.
9. Sodek J, Overall C. Matrix degradation in hard and soft connective tissue. In: Davidovitch Z, ed. The Biological Mechanisms of Tooth Eruption and Root Resorption. Birmingham, AL: EBSCO; 1988:303-312.
10. Salo T, Oikarinen KS, Oikarinen AI. Effect of phenytoin and nifedipine on collagen gene expression in human gingival fibroblasts. J Oral Pathol Med 1990;19:404-407.
11. Fujii A, Matsumoto H, Nakano S, et al. Effect of calcium-channel blockers on cell proliferation, DNA synthesis and collagen synthesis of cultured gingival fibroblasts derived from human nifedipine responders and non-responders. Arch Oral Biol 1994;39:99-104.
12. Tipton DA, Fry HR, Dabbous MK. Altered collagen metabolism in nifedipine-induced gingival overgrowth. J Periodont Res 1994;29:401-409.
13. Everts V, Wolvius E, Saklatvala J, Beertsen W. Interleukin 1 increases the production of collagenase but does not influence the phagocytosis of collagen fibrils. Matrix 1990;10:388-393.
14. Van der Zee E, Everts V, Beertsen W. Cytokines modulate route of collagen breakdown. Review with special emphasis on mechanisms of collagen degradation in the periodontium and the burst hypothesis of periodontal disease progression. J Clin Periodontol 1997;24:297-305.
15. Nishikawa S, Nagata T, Morisaki I, et al. Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model. J Periodontol 1996;67:463-471.
16. Ishida H, Kondoh T, Kataoka M, et al. Factors influencing nifedipine-induced gingival overgrowth in rats. J Periodontol 1995;66:345-350.
17. Ohsaki Y, Nagata K. Type III collagen is a major component of interodontoblastic fibers of the developing mouse molar root. Anat Rec 1994;240:308-313.
18. Kataoka M, Shimizu Y, Kunikiyo K, et al. Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth. J Cell Physiol 2000;182:351-358.
19. Genovese C, Rowe D, Kream B. Construction of DNA sequences complementary to rat α1 and α2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochem 1984;23:6210-6216.
20. Tso JY, Sun XH, Kao TH, et al. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985;13: 2485-2502.
21. McCulloch CAG, Knowles GC. Deficiencies in collagen phagocytosis by human fibroblasts in vitro: A mechanism for fibrosis? J Cell Physiol 1993;155:461-471.
22. Saito K, Mori S, Iwakura M, Sakamoto S. Immunohistochemical localization of transforming growth factor β, basic fibroblast growth factor and heparan sulfate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin. J Periodont Res 1996;31:545-555.
23. Boltchi FE, Rees TD, Iacopino AM. Cyclosporin A-induced gingival overgrowth: A comprehensive review. Quintessence Int 1999;30:775-783.
24. Korn JH, Thrall RS, Wilbar DC, et al. Fibroblast heterogeneity: Clonal selection of fibroblasts as a model for fibrotic disease. In: Philipps RP, ed. Pulmonary Fibroblast Heterogeneity. Boca Raton, FL: CRC Press; 1992: 119-133.
25. Kitamura K, Morisaki I, Adachi C, et al. Gingival over-growth induced by cyclosporin A in rats. Arch Oral Biol 1990;35:483-486.
26. Morisaki I, Kitamura K, Kato K, et al. Age dependency of cyclosporin A-induced gingival overgrowth in rats. Pediatr Dent 1993;15:414-417.
27. Kozlowska E, Sollberg S, Mauch C, et al. Decreased expression of α2β1 integrin in scleroderma fibroblasts. Exp Dermatol 1996;5:57-63.
28. Dickeson SK, Mathis NL, Rahman M, et al. Determinants of ligand binding specificity of the α1β1 and α2β2 integrins. J Biol Chem 1999;274:32182-32191.
29. Lee W, Sodek J, McCulloch CAG. Role of integrins in regulation of collagen phagocytosis by human fibroblasts. J Cell Physiol 1996;168:695-704.
30. Timar J, Chopra H, Rong X, et al. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin αIIβb3 and tumor-cell-induced platelet aggregation. J Cancer Res Clin Oncol 1992;118:425-434.